Show simple item record

dc.contributor.authorRiccaboni, Massimo
dc.contributor.authorSwoboda, Torben
dc.contributor.authorVan Dyck, Walter
dc.date.accessioned2022-11-04T07:50:02Z
dc.date.available2022-11-04T07:50:02Z
dc.date.issued2022en_US
dc.identifier.issn0168-8510
dc.identifier.doi10.1016/j.healthpol.2022.03.013
dc.identifier.urihttp://hdl.handle.net/20.500.12127/7139
dc.description.abstractWith pharmaceutical health policy striving for fair and sustainable pricing under increasing budgetary pressures, public stakeholders are more and more willing to be involved in transparent access decision-making related to novel medicines, considered by them to be a societal good. Full net price transparency (NPT) is believed by many to promote price competition and to increase equity by making pharmaceutical products accessible to all. Using agent-based simulations, we find that a full NPT system implemented across EU countries would not be viable. This while, acting as rational economic agents, a group of middle- and lower-income countries would not be willing to give up their confidential agreements with the pharmaceutical industry. Even partial NPT would delay access predominantly in middle- to lower-income countries. Hence, we conclude that implementing net price transparency across Europe would be challenging to reach from a political perspective. Especially in lower-income countries there would remain a plea to be left free to negotiate confidential discounts with drug manufacturers. This while, counterintuitively, in those countries NPT will be seen to be unjust while violating Ramsey pricing and distributive justice principles.en_US
dc.language.isoenen_US
dc.publisherElsevier Irelanden_US
dc.subjectPharmaceutical Pricingen_US
dc.subjectEuropean Unionen_US
dc.subjectPrice Transparencyen_US
dc.subjectInternational Reference Pricingen_US
dc.subjectInnovative Drugsen_US
dc.titlePharmaceutical net price transparency across European markets: Insights from a multi-agent simulation modelen_US
dc.identifier.journalHealth Policyen_US
dc.source.volume126en_US
dc.source.issue6en_US
dc.source.beginpage534en_US
dc.source.endpage540en_US
dc.contributor.departmentIMT School for Advanced Studies, Lucca, Italyen_US
dc.contributor.departmentInstitute of Philosophy, KU Leuven, Leuven, Belgiumen_US
dc.identifier.eissn1872-6054
vlerick.knowledgedomainOperations & Supply Chain Managementen_US
vlerick.knowledgedomainSpecial Industries : Healthcare Managementen_US
vlerick.typearticleVlerick strategic journal articleen_US
vlerick.vlerickdepartmentTOMen_US
dc.identifier.vperid285917en_US
dc.identifier.vperid31183en_US


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record